tiprankstipranks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market

Estrella Immunopharma (ESLA) Stock Price & Analysis

15 Followers

ESLA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.86 - $33.00
Previous Close$1.12
Volume59.27K
Average Volume (3M)34.01K
Market Cap
$37.71M
Enterprise Value$19.17M
Total Cash (Recent Filing)$22.14M
Total Debt (Recent Filing)$300.00K
Price to Earnings (P/E)-6.1
Beta0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding36,610,870
10 Day Avg. Volume14,264
30 Day Avg. Volume34,008
Standard Deviation0.18
R-Squared0.00131
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.94
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-36.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

3.42%0.04%0.20%96.33%
0.20% Other Institutional Investors
96.33% Public Companies and
Individual Investors

ESLA FAQ

What was Estrella Immunopharma’s price range in the past 12 months?
Estrella Immunopharma lowest stock price was $0.86 and its highest was $33.00 in the past 12 months.
    What is Estrella Immunopharma’s market cap?
    Currently, no data Available
    When is Estrella Immunopharma’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Estrella Immunopharma’s earnings last quarter?
    Currently, no data Available
    Is Estrella Immunopharma overvalued?
    According to Wall Street analysts Estrella Immunopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Estrella Immunopharma pay dividends?
      Estrella Immunopharma does not currently pay dividends.
      What is Estrella Immunopharma’s EPS estimate?
      Estrella Immunopharma’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Estrella Immunopharma have?
      Estrella Immunopharma has 36,610,870 shares outstanding.
        What happened to Estrella Immunopharma’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Estrella Immunopharma?
        Among the largest hedge funds holding Estrella Immunopharma’s share is Owl Creek Asset Management, L.P.. It holds Estrella Immunopharma’s shares valued at N/A.
          ---

          Estrella Immunopharma Stock Smart Score

          Company Description

          Estrella Immunopharma

          TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Arrowhead Pharmaceuticals
          Corvus Pharmaceuticals
          Advaxis
          Adaptimmune Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis